St. Jude Medical Announces Approval and Launch of Neurostimulation System in Japan

The Genesis(TM) spinal cord stimulator has received regulatory approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) for the management of chronic pain. The implanted device sends mild electrical pulses to leads located near the spinal cord to interrupt the pain signals as they travel to the brain. This system is also approved in the U.S., European Union, Canada, Australia, and select Latin American and Asian markets. Medical image provided by St. Jude Medical

The Genesis(TM) spinal cord stimulation system has received regulatory approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) for the management of chronic pain. The implanted device sends mild electrical pulses to leads located near the spinal cord to interrupt the pain signals as they travel to the brain. This system is also approved in the U.S., European Union, Canada, Australia, and select Latin American and Asian markets. Medical image provided by St. Jude Medical